AT2 receptors: Functional relevance in cardiovascular disease
Authors:
- Antony VinhAVAntony Vinh
- Claudia A. McCarthyCMClaudia A. McCarthy
- Tracey A. GaspariTGTracey A. Gaspari
- Robert E. WiddopRWRobert E. Widdop
- 1 December 2008
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 120 (3) , 292-316
Abstract
No abstract availableKeywords
This publication has 437 references indexed in Scilit:
- Mechanisms of the Anti-Ischemic Effect of Angiotensin II AT1 Receptor Antagonists in the BrainCellular and Molecular Neurobiology, 2006
- Differential effect of losartan in female and male spontaneously hypertensive ratsLife Sciences, 2006
- Taurine May Prevent Diabetic Rats from Developing Cardiomyopathy also by Downregulating Angiotensin II Type2 Receptor ExpressionCardiovascular Drugs and Therapy, 2005
- ATRAP, Novel AT1 Receptor Associated Protein, Enhances Internalization of AT1 Receptor and Inhibits Vascular Smooth Muscle Cell GrowthBiochemical and Biophysical Research Communications, 2000
- Tissue angiotensin II and endothelin‐1 modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive ratsBritish Journal of Pharmacology, 2000
- Angiotensin II Receptor AntagonistsDrugs & Aging, 1997
- Angiotensin II Increases cGMP Content Via Endothelial Angiotensin II AT1 Subtype Receptors in the Rat Carotid ArteryArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- The angiotensin AT2 receptor stimulates protein tyrosine phosphatase activity and mediates inhibition of particulate guanylate cyclaseBiochemical and Biophysical Research Communications, 1992
- Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart StudyNew England Journal of Medicine, 1990
- Preliminary biochemical characterization of two angiotensin II receptor subtypesBiochemical and Biophysical Research Communications, 1989